We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQ icon
3276
CALL
iQIYI
IQ
$1.31B
$200K ﹤0.01%
98,800
+23,600
+31% +$703K
TGP
3277
DELISTED
Teekay LNG Partners L.P.
TGP
$200K ﹤0.01%
11,978
-976
-8% -$15.6K
NCV
3278
Virtus Convertible & Income Fund
NCV
$391M
$199K ﹤0.01%
7,164
-996
-12% -$28.1K
EFT
3279
Eaton Vance Floating-Rate Income Trust
EFT
$288M
$197K ﹤0.01%
13,482
-70
-0.5% -$1.03K
FLWS icon
3280
1-800-Flowers.com
FLWS
$255M
$197K ﹤0.01%
16,655
+2,455
+17% +$31.8K
MCHP icon
3281
CALL
Microchip Technology
MCHP
$44.2B
$196K ﹤0.01%
780,200
+501,000
+179% +$22.1M
ADAP
3282
DELISTED
Adaptimmune Therapeutics
ADAP
$195K ﹤0.01%
14,408
-1,188
-8% -$12.5K
NMTR
3283
DELISTED
9 Meters Biopharma
NMTR
$195K ﹤0.01%
+1,426
New +$245K
IHD
3284
Voya Emerging Markets High Income Dividend Equity Fund
IHD
$132M
$193K ﹤0.01%
23,972
+4,570
+24% +$35.7K
NIM icon
3285
Nuveen Select Maturities Municipal Fund
NIM
$116M
$192K ﹤0.01%
20,003
SMRT
3286
DELISTED
Stein Mart Inc
SMRT
$192K ﹤0.01%
81,512
-50,396
-38% -$116K
BHV icon
3287
BlackRock Virginia Muni Bond Trust
BHV
$20.3M
$191K ﹤0.01%
10,966
-2,500
-19% -$41.9K
CNR
3288
DELISTED
Cornerstone Building Brands, Inc.
CNR
$191K ﹤0.01%
+12,614
New +$210K
FULT icon
3289
Fulton Financial
FULT
$4.6B
$190K ﹤0.01%
11,418
+526
+5% +$9.2K
HD icon
3290
CALL
Home Depot
HD
$350B
$190K ﹤0.01%
66,800
+21,800
+48% +$4.39M
NNY icon
3291
Nuveen New York Municipal Value Fund
NNY
$156M
$190K ﹤0.01%
20,105
-3,100
-13% -$28.7K
AGRO icon
3292
Adecoagro
AGRO
$1.39B
$189K ﹤0.01%
25,693
-3,497
-12% -$28.2K
EMF
3293
Templeton Emerging Markets Fund
EMF
$324M
$189K ﹤0.01%
12,896
+150
+1% +$2.18K
ORCL icon
3294
CALL
Oracle
ORCL
$435B
$189K ﹤0.01%
204,500
-80,500
-28% -$3.91M
RWT
3295
Redwood Trust
RWT
$574M
$189K ﹤0.01%
11,619
+454
+4% +$7.52K
NPTN
3296
DELISTED
NEOPHOTONICS CORP
NPTN
$189K ﹤0.01%
22,800
-57,550
-72% -$438K
EVG
3297
Eaton Vance Short Duration Diversified Income Fund
EVG
$143M
$188K ﹤0.01%
14,554
-44,215
-75% -$572K
MAT icon
3298
Mattel
MAT
$4.21B
$188K ﹤0.01%
12,002
-5,560
-32% -$89K
PCN
3299
PIMCO Corporate & Income Strategy Fund
PCN
$889M
$188K ﹤0.01%
+10,276
New +$187K
GWRS icon
3300
Global Water Resources
GWRS
$212M
$187K ﹤0.01%
17,700

Similar funds

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.